Michels Family Financial’s GSK GSK Stock Holding History

Michels Family Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$650K	Buy	12,393 +282	+2%	+$14.9K	0.42%	75
2026 Q1	$668K	Sell	12,111 -640	-5%	-$34.7K	0.48%	67
2025 Q4	$625K	Buy	12,751 +534	+4%	+$24.9K	0.46%	71
2025 Q3	$527K	Buy	12,217 +365	+3%	+$14.3K	0.41%	81
2025 Q2	$455K	Buy	11,852 +284	+2%	+$10.9K	0.39%	83
2025 Q1	$448K	Buy	11,568 +418	+4%	+$15.3K	0.41%	86
2024 Q4	$377K	Buy	+11,150	New	+$401K	0.35%	95

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Michels Family Financial's GSK Position: Q2 2026 in Review

Michels Family Financial increased its GSK (GSK) stake by 2.3% in Q2 2026, buying an estimated $14.9K and bringing the position to 12,393 shares worth $650K. The position accounts for 0.42% of the portfolio, ranked #75.

Michels Family Financial first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $668K in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Michels Family Financial held 12,393 shares of GSK worth $650K as of Q2 2026.
Michels Family Financial bought 282 GSK shares in Q2 2026, an estimated $14.9K.
GSK made up 0.42% of Michels Family Financial's portfolio in Q2 2026, its #75 holding.
Michels Family Financial first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
Michels Family Financial's GSK position peaked at $668K in Q1 2026.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Michels Family Financial's 13F filing for Q2 2026, filed 14 Aug 2026.